comparemela.com

Latest Breaking News On - Boehringer ingelheim venture fund - Page 4 : comparemela.com

Actym Raises $59.5M In Series A funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Berkeley
California
United-states
Christopher-thanos
Boehringer-ingelheim-venture-fund
Actym-therapeutics
Illumina-ventures
Panacea-ventures

Dopavision Reports Successful Completion of Enrollment for MyopiaX-1 Trial

- MyopiaX-1 trial to generate first clinical evidence with MyopiaX®,a novel therapeutic approach to manage myopia progression

Dublin
Ireland
Berlin
Germany
London
City-of
United-kingdom
Portugal
Spain
Netherlands
Madrid
Moorfields

Dopavision Reports Successful Completion of Enrollment for

- MyopiaX-1 trial to generate first clinical evidence with MyopiaX®, a novel therapeutic approach to manage myopia progression- First data readout expected.

Moorfields
Ballymena
United-kingdom
Portugal
Netherlands
Germany
Berlin
Dublin
Ireland
London
City-of
Spain

Analysis of the Global AI in Clinical Trials Industry, 2023 to 2035 - Product/Technology Utilization and Integration Agreements Lead the Way in Partnerships

/PRNewswire/ The "Global AI in Clinical Trials Market: Trends and Forecasts 2023-2035" report has been added to ResearchAndMarkets.com s offering. The.

United-states
Iowa
Herefordshire
United-kingdom
Alexandria
Al-iskandariyah
Egypt
France
Gloucestershire
India
Australia
Charterhouse

Global AI in Clinical Trials Market Overview 2023-2035: AI

Dublin, Aug. 18, 2023 (GLOBE NEWSWIRE) The "AI in Clinical Trials Market: Software and Service Providers - Distribution by Trial Phase, Target.

Northpond
New-york
United-states
Worcestershire
United-kingdom
Menlo
Iowa
Memorial-sloan-kettering-cancer-center
Ohio
Springrock
California
Charterhouse

vimarsana © 2020. All Rights Reserved.